Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 1245

1245. Deputy Michael Cahill asked the Minister for Health the status of the roll out of Skyclarys (omaveloxolone) for patients with Friedreich's ataxia; the reason for delays following re-imbursement approval; when eligible patients can expect to access the treatment; and if she will make a statement on the matter. [64785/26]

askedIreland· Dáil Éireann· EN

Introduced

16 September 2026

Last action

16 September 2026 · Medicinal Products

Status

written

Sponsors

Michael Cahill

Subjects

Discovery layer

Source updated

16 September 2026

Summary

1245. Deputy Michael Cahill asked the Minister for Health the status of the roll out of Skyclarys (omaveloxolone) for patients with Friedreich's ataxia; the reason for delays following re-imbursement approval; when eligible patients can expect to access the treatment; and if she will make a statement on the matter. [64785/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 September 2026

    Medicinal Products

    1245. Deputy Michael Cahill asked the Minister for Health the status of the roll out of Skyclarys (omaveloxolone) for patients with Friedreich's ataxia; the reason for delays following re-imbursement approval; when eligible patients can expect to access the treatment; and if she will make a statement on the matter. [64785/26]

    Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products

View fileDownload file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.